This article has Open Peer Review reports available.
T-helper-associated cytokines expression by peripheral blood mononuclear cells in patients with polypoidal choroidal vasculopathy and age-related macular degeneration
© Yu et al. 2016
Received: 14 December 2015
Accepted: 21 May 2016
Published: 7 June 2016
Immune responses play a key role in the pathogenesis and progression of polypoidal choroidal vasculopath (PCV) and age-related macular degeneration (AMD). In this study, we determined the Th cell-associated immune responses by measuring the cytokine expression of peripheral blood mononuclear cells (PBMC) in both PCV and neovascular AMD (nAMD) patients.
Twenty-seven nAMD patients, 33 PCV patients and a gender- and age-matched group of 18 healthy individuals were involved in this study. The Th-cell cytokine profiles including levels of interferon-gamma (INF-γ), interleukin (IL)-17A and IL-4 in cultures of PBMCs were determined by enzyme-linked immunosorbent assay (ELISA).
IFN-γ,IL-17A and IL-4 production was significantly increased after stimulation with PHA. The levels of IFN-γ and IL-4 in PHA-stimulated cultures were higher in PCV and nAMD patients than that in healthy controls (P = 0.038,P = 0.014), while no difference was found between PCV and nAMD (all P > 0.05). No significant difference in IL-17A level in PHA-stimulated cultures was found among PCV, nAMD and control groups (P > 0.05).
These findings suggest that circulating IFN-γ and IL-4 producing Th1 and Th2 cells may involve in the pathogenesis of PCV and nAMD. PCV may have the similar immune responses with nAMD.
KeywordsT-helper cell Cytokine Peripheral blood mononuclear cell Age-related macular degeneration Polypoidal choroidal vasculopath
Age-related macular degeneration (AMD) is a leading cause of irreversible visual disability and blindness among elderly in developed countries . An advanced stage of AMD is characterized by choroidal neovascularization (neovascular AMD, nAMD) or geographic atrophy. Polypoidal choroidal vasculopath (PCV) exhibits commonalities with nAMD in that both are choroidal vasculopathy associated with subretinal hemorrhage, scars and fibrosis . However, PCV is characterized by inner choroidal vascular networks ending in polypoidal structures at the borders of the lesion, while nAMD is characterized by choroidal neovascularization . PCV still remains a subject of debate as to whether it is a subtype of AMD or its own distinct entity. The differences between the pathogeneses of PCV and nAMD are still unknown.
Recent information supports the notion that immune mechanisms play an important and perhaps central role in the pathogenesis of AMD . CD4+ T cells are key players in immune responses. Among the T-helper cells, each subset produces different effector cytokines. Th1 cells predominantly secrete Interferon-gamma (IFN-γ), Th2 cells primarily produce IL-4 , CD4+ Th cells also produce IL-17, denoted as Th17 cells . It is suggests that the underlying mechanism leading to AMD is the decline of the ocular down-regulatory immune environment . The subsequent activation of the immune system would lead to T-cell sensitization. The accumulation of complement component 5a (C5a) and C3a in drusen promote choroidal neovascularization (CNV), which is the hallmark of wet AMD . C5a promotes interleukin (IL)-22 and IL-17 expression by human CD4+ T cells . IL-17A was initially reported to be mainly expressed by activated CD4+ T cells. It was implicated in the pathogenesis of various autoimmune diseases including uveitis, arthritis, multiple sclerosis and inflammatory bowel disease . IL-17A rs2275913G/A and rs3748067C/T polymorphisms are associated with increased risk of AMD . IFN-γ, a soluble cytokine associated with innate and adaptive immunity, is considered to be a pro-inflammatory factor. Constituents of drusen such as amyloid beta and advanced glycation endproducts (AGE) are capable of activating the IFN-γ pathway . IFN-γ promotes proinflammatory responses by activating proinflammatory cytokines and chemokines, thereby recruiting immune cells such as macrophages, microglia, NK and T cells into inflammatory sites [13, 14]. IFN-γ induces a dose- and time-dependent increase in complement factor B mRNA expression in primary macrophages and macrophage cell lines  and increases CXCL11 mRNA expression and CXCL11 protein secretion by ARPE-19 cells . IFN-γ also induces VEGF expression in human retinal pigment epithelial cells. Unexpectedly, IFNγ-induced VEGF secretion in human retinal pigment epithelial cells (RPE) was not through the classic IFN-γ Jak/Stat1 pathway, but through the PI-3 K/mTOR/p70-S6K-translational regulation pathway . In laser-induced CNV model, NK cell depletion leads to decreased areas of CNV, macrophage infiltration and reduced mRNA expression of VEGFs and IFN-γ in the choroid, suggesting that IFN-γ-secreting NK cells promote angiogenesis by enhancing VEGF expression via macrophage activation . IFN-γ may involve in AMD pathogenesis through macrophage polarization. INF-γ can selectively promote polarization into M1 subtype . M1 subtype is predominantly proinflammatory and there is a pathological shift towards M1 subtype with the development of AMD .
Although IFN-γ and IL-17 are shown to be the major product of inflammasome cascade activation, few study focus on the immune-inflammatory response of PCV. The Th-cytokine levels of PCV and nAMD in peripheral blood mononuclear cells (PBMCs) have not been previously studied. In the present study, we studied the production of IFN-γ, IL-17A, and IL-4 in cultures of PBMCs from PCV and nAMD patients.
Subjects and sample preparation
Twenty-seven nAMD patients, 33 PCV patients and a gender- and age-matched group of 18 healthy individuals were selected from the Outpatient Clinics at the Zhongshan Ophthalmic Centre for the study. Informed consent was obtained from all patients and controls before entering the study. Research was performed in accordance with the ethical standards of the Declaration of Helsinki and the internal Ethics Committees of Sun Yat-sen University, Guangzhou, China, which approved all of the protocols.
Only patients without infectious diseases and not using immunosuppressive drugs were enrolled in the study. Moreover, patients with other neovascularized maculopathies, such as pathologic myopia, angioid streaks, and retinal angiomatous proliferation were excluded. Patients with media opacities preventing clear visualization of the macula were excluded from the study. Patients received intravitreal anti-vascular endothelial growth factor (VEGF) therapy were also excluded from the study.
The diagnosis of PCV was based on identification of characteristic polypoidal choroidal vascular dilations with or without branching inner choroidal vessels on ICGA. All PCV patients enrolled in this study met the criteria of definitive cases of PCV, as proposed by the Japanese Study Group of PCV . Cases diagnosed as probable were excluded because they were difficult to distinguish from AMD cases. The diagnosis of nAMD was based on identification of choroidal neovascularization by fluorescein angiography and ICGA. All nAMD cases were classified as stage 4 by the Rotterdam Study classification .
A whole-blood (12 ml) sample was taken from each study participant and placed in a sterile tube containing lithium heparin as anticoagulant (Vacutainer, BD) for the cell proliferation test and cytokine.
Cell isolation and culture
The PBMCs were prepared from heparinized blood by Ficoll-Hypaque density-gradient centrifugation. To study the production of IFN-γ, IL-17 and IL-4, PBMCs were stimulated with PHA at a density of 2 × 106 cells/ml. Isolated PBMCs were stimulated for 48 h and subsequently used for IFN-γ, IL-17 and IL-4 analysis by ELISA.
ELISA for IFN-γ, IL-17 and IL-4
The protein levels of IFN-γ, IL-17 and IL-4 in the collected supernatants were measured using a Duoset ELISA development kit (R&D Systems). The minimal detectable concentration was 15 pg/ml for IFN-γ, IL-17 and IL-4. All samples were measured in duplicate.
All analyses were performed using the Statistical Package for the Social Sciences statistical software for Windows, version 17.0 (SPSS Inc.). Group differences among diabetics and controls were analyzed using one-way ANOVA or nonparametric Kruskal–Wallis tests, depending on normality assumptions and the homogeneity of variances. The parameters showing statistically significant differences among all groups were further analyzed using the Mann–Whitney-U test or Student’s t-test. Differences within groups before and after stimulation were analyzed by Wilcoxon test. The correlations among study parameters were analyzed by Spearman’s correlation test. Differences in baseline gender among cases and controls were assessed using χ2 tests for proportions. For all tests, P values < 0.05 were considered statistically significant. Graphs were prepared by using Prism version 5 (GraphPad Software Inc., La Jolla, USA).
Clinical characteristics of the patients
Clinical and biochemical characteristics of PCV, nAMD and control subjects
64.38 ± 11.92
64.79 ± 9.35
64.15 ± 9.30
23.17 ± 2.02
21.21 ± 2.20
23.21 ± 3.64
Concentrations of IFN-γ,IL-17A and IL-4 in the supernatants of cultured PBMCs
Concentrations of IL-17A in culture supernatants of unstimulated or activated PBMCs from PCV, nAMD and healthy controls
(N = 18)
(N = 33)
(N = 27)
20.61 ± 45.23
45.25 ± 65.76
46.01 ± 65.76
1215.53 ± 875.21
1218.08 ± 860.30
942.09 ± 570.23
Concentrations of IFN-γ, IL-17A and IL-4 in culture supernatants of activated PBMCs from PCV, nAMD and healthy controls
(N = 18)
(N = 33)
(N = 27)
135.90 ± 130.61
341.37 ± 341.96
393.42 ± 404.35
1215.53 ± 875.21
1218.08 ± 860.30
942.09 ± 570.23
7.34 ± 23.24
42.08 ± 83.97
29.53 ± 69.46
IFN-γ and IL-4 levels were markedly elevated in the PCV and nAMD
Correlation analyses in PCV and nAMD
There is more and more evidence for immune response involve in the pathogenesis and progression of AMD. Retinal pigment epithelial (RPE) cell is one of the most important systems that regulate the immune response in the eye. RPE cell represents a primary site of pathology in AMD and their function and phenotype may modify by cytokines and inflammatory mediators. Dysfunction of RPE cells could trigger the inflammatory response, which then could trigger the photoreceptor degeneration and neovascularization in the retinas . This might be one of the mechanisms of PCV and nAMD development. A few data on these immuno-inflammatory cytokines expression in PCV were reported. We therefore examined the levels of Th cytokines of PCV and nAMD patients. Our result showed that IFN-γ levels in the supernatants of cultured PBMCs in PCV and nAMD patients were markedly elevated compared with normal controls, indicating that IFN-γ related inflammatory pathway may involve in the pathogenesis of PCV and nAMD.
Recent studies point towards an emerging relationship between IFN-γ and mechanisms underlying the pathogenesis of AMD. The interaction of pathways activated by IFN-γ is complex and not fully understood. IFN-γ is classically considered as a pro-inflammatory factor, yet in recent years, multiple studies find IFN-γ to mediate an immune-modulatory and protective function. IFN-γ increases complement factor H (CFH) expression in cultured human RPE . CFH is a major inhibitor of the alternative complement activation pathway that plays a critical role in driving the inflammatory responses in outer retina and is associated with AMD pathogenesis . In human endothelial cells IFN-γ inhibits the angiogenic activity of VEGF through activation of STAT1 pathway. This may inhibit excess angiogenesis process in wet AMD . Another study suggests that IFN-γ induces VEGF expression in human retinal pigment epithelial cells . The activation of the PI-3 K/mTOR/translational pathway is important for IFN-γ-mediated VEGF expression in RPE cells. It is known that STAT1-deficient mouse are highly susceptible to autoimmune disorders, thus STAT1 activation by IFN-γ may be important in mitigating AMD progression .
IFN-γ may also play a beneficial role by regulating Th17 cells. IL-17A is an important cytokine implicated in the pathogenesis of autoimmune disease . Our data indicate that no significant difference in IL-17A levels in PHA-stimulated cultures among PCV, nAMD and control groups. It is reported that in vitro stimulated PBMCs carrying rs2275913AA genotype produced significantly more IL-17 than those with the GG genotype, and similar data were observed in both controls and AMD patients . In paraffin-embedded tissues, expression of IL17A mRNA and the receptor IL17RC mRNA are higher in the macula of AMD patients than in control . In vitro, IL17A induces RPE cell death characterized by the accumulation of cytoplasmic lipids and autophagosomes with subsequent activation of pro-apoptotic Caspase-3 and Caspase-9 . Aqueous humor levels of IL-17 in eyes with nAMD or PCV are not statistically different from those in control eyes . This result is consistent with our results. The different results are owing to different sample tissue, target population, detection mean and so on. Further studies are needed to clarify the role of Th17 in these patients.
In our analyses of serum cytokine profiles, IL-4 level in PHA-stimulated cultures was higher in PCV and nAMD patients than that in healthy controls. IL-4, a cytokine of Th2 subtype, plays an important role in humoral and cell-mediated immunity . AGEs are a constituent of drusen and accumulate in Bruch’s membrane with age. IL-4 in supernatant samples from AGE stimulation of human RPE cells is 5.5 fold changes over controls . Aqueous humor levels of IL-4 in eyes with nAMD or PCV are not statistically different from those in control eyes . The levels of IL-4 in the aqueous humor samples from PCV patients are significantly higher than in the controls.
However, we were unable to distinguish nAMD and PCV from PHA-stimulated PBMCs based the expression of IFN-γ and IL-4. The reason remains unclear as the number of subjects enrolled in our present study was limited. One possibility is that IFN-γ and IL-4 is upregulated in both PCV and nAMD conditions but with different level and time window which may further trigger different signaling pathways and lead to different abnormal angiogenesis process. Another possibility is that PCV may have similar immune character with nAMD. PCV has many similarities with neovascular AMD, including clinical manifestations, genetic background, and epidemiological features . It remains controversial as to whether or not PCV represents a subtype of nAMD. In clinical, some patients have possibility having CNV we cannot distinguish PCV from neovascular AMD. ‘Probable’ cases were determined if at least one of the following criteria were met: 1. only an abnormal vascular network is seen in ICGA. 2. Recurrent hemorrhagic and/or serous detachments of the RPE were observed . From view of immune character, aqueous humor concentrations of CRP and IP-10 were elevated in eyes with PCV or nAMD. None of the 14 cytokines, including VEGF, IL-1α, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13, IL-15, IL-17, monocyte chemoattractant protein 1, were significantly different between eyes with nAMD and those with PCV . It is reported that PCV and nAMD have common associations with the complement factor H (CFH) and the HtrA serine peptidase 1 (HTRA1) genes [31, 32], which suggests some genetic similarity between these two entities. ARMS2/HTRA1 locus has a strong and consistent association with both exudative AMD and PCV, suggesting the two disorders share, at least partially, similar molecular mechanisms .
In our previous study, we identified a variant in chromosome 9p21, well known to be associated with coronary artery disease and type 2 diabetes, was significantly associated with PCV but not with neovascular AMD in the Chinese Han population . The rs42524 polymorphism is a risk allele for nAMD in a Han Chinese population . However, rs42524 in COL1A2 confers different levels of susceptibility to nAMD and PCV  Thus, the different role of IFN-γ and IL-4 in the development of PCV and nAMD needs to be verified in further studies.
The major limitation of this study is the relatively small sample size. Additionally, no mechanistic and functional evaluations were conducted in this study. Extended cohorts with both PCV and nAMD patients offering higher statistical power will be necessary to confirm our results.
In summary, our data show that circulating IFN-γ-producing Th1 cells and IL-4-producing Th2 cells is associated with the pathogenesis of PCV and nAMD. There is no significant difference in IFN-γ, IL-17A and IL-4 levels in the supernatants of cultured PBMCs between PCV and nAMD, indicating PCV may have the similar immune character with nAMD.
AMD, age-related macular degeneration; CFH, complement factor H; CNV, choroidal neovascularization; IL, interleukin; INF-γ, interferon-gamma; PBMCs, peripheral blood mononuclear cells; PCV, polypoidal choroidal vasculopath; RPE, retinal pigment epithelial; VEGF, vascular endothelial growth factor.
This project was supported in part by the grants from the National Natural Science Foundation of China (grant number: 31471122).
The authors declare that no funding support was received for this study.
Availability of data and materials
All the data supporting our findings is contained within the manuscript.
SS and FW designed the study, monitored data collection, revised and approved the paper. YY drafted the paper and completed the statistical analysis. XR and HC were responsible for the collection of cases and performed the experiments. All authors have read and approve of the final version of the manuscript.
The authors declare that they have no competing interests.
Consent to publish
Ethics and consent to participate
The study protocol was reviewed and approved by the Medical Ethics Committee of the Zhongshan Ophthalmic Center, Sun Yat-sen University (No. 2012KYNL015). It also strictly adhered to the principles of the Declaration of Helsinki. All subjects signed informed consent forms prior to participation.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol. 2006;51(4):316–63.View ArticlePubMedGoogle Scholar
- Laude A, Cackett PD, Vithana EN, Yeo IY, Wong D, Koh AH, Wong TY, Aung T. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res. 2010;29(1):19–29.View ArticlePubMedGoogle Scholar
- Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA. Polypoidal choroidal vasculopathy. Surv Ophthalmol. 2004;49(1):25–37.View ArticlePubMedGoogle Scholar
- Blasiak J, Petrovski G, Vereb Z, Facsko A, Kaarniranta K. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. BioMed Res Int. 2014;2014:768026.View ArticlePubMedPubMed CentralGoogle Scholar
- Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol. 1995;15(3):121–9.View ArticlePubMedGoogle Scholar
- Benedetti G, Miossec P. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur J Immunol. 2014;44(2):339–47.View ArticlePubMedGoogle Scholar
- Nussenblatt RB, Ferris 3rd F. Age-related macular degeneration and the immune response: implications for therapy. Am J Ophthalmol. 2007;144(4):618–26.View ArticlePubMedPubMed CentralGoogle Scholar
- Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, Chen Y, Zhang K, Ambati BK, Baffi JZ et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A. 2006;103(7):2328–33.View ArticlePubMedPubMed CentralGoogle Scholar
- Liu B, Wei L, Meyerle C, Tuo J, Sen HN, Li Z, Chakrabarty S, Agron E, Chan CC, Klein ML et al. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med. 2011;9:1–12.View ArticlePubMedGoogle Scholar
- Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821–52.View ArticlePubMedGoogle Scholar
- Zhang S, Liu Y, Lu S, Cai X. Genetic variants of interleukin 17A are functionally associated with increased risk of age-related macular degeneration. Inflammation. 2015;38(2):658–63.View ArticlePubMedGoogle Scholar
- Kurji KH, Cui JZ, Lin T, Harriman D, Prasad SS, Kojic L, Matsubara JA. Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-beta stimulation of cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2010;51(2):1151–63.View ArticlePubMedGoogle Scholar
- Jiang K, Cao S, Cui JZ, Matsubara JA. Immuno-modulatory Effect of IFN-gamma in AMD and its Role as a Possible Target for Therapy. J Clin Exp Ophthalmol. 2013;Suppl 2:0071–76.Google Scholar
- Chakrabarty P, Ceballos-Diaz C, Beccard A, Janus C, Dickson D, Golde TE, Das P. IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. J Immunol. 2010;184(9):5333–43.View ArticlePubMedPubMed CentralGoogle Scholar
- Huang Y, Krein PM, Winston BW. Characterization of IFN-gamma regulation of the complement factor B gene in macrophages. Eur J Immunol. 2001;31(12):3676–86.View ArticlePubMedGoogle Scholar
- Kutty RK, Samuel W, Abay R, Cherukuri A, Nagineni CN, Duncan T, Jaworski C, Vijayasarathy C, Redmond TM. Resveratrol attenuates CXCL11 expression induced by proinflammatory cytokines in retinal pigment epithelial cells. Cytokine. 2015;74(2):335–8.View ArticlePubMedGoogle Scholar
- Liu B, Faia L, Hu M, Nussenblatt RB. Pro-angiogenic effect of IFNgamma is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells. Mol Vis. 2010;16:184–93.PubMedPubMed CentralGoogle Scholar
- Lee H, Schlereth SL, Park EY, Emami-Naeini P, Chauhan SK, Dana R. A novel pro-angiogenic function for interferon-gamma-secreting natural killer cells. Invest Ophthalmol Vis Sci. 2014;55(5):2885–92.View ArticlePubMedPubMed CentralGoogle Scholar
- Brown J, Wallet MA, Krastins B, Sarracino D, Goodenow MM. Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages. J Leukoc Biol. 2010;87(4):655–62.View ArticlePubMedPubMed CentralGoogle Scholar
- Japanese Study Group of Polypoidal Choroidal V. Criteria for diagnosis of polypoidal choroidal vasculopathy. Nippon Ganka Gakkai Zasshi. 2005;109(7):417–27.Google Scholar
- van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol. 2003;121(4):519–26.View ArticlePubMedGoogle Scholar
- Kaarniranta K, Salminen A. Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors. J Mol Med. 2009;87(2):117–23.View ArticlePubMedGoogle Scholar
- Lau LI, Chiou SH, Liu CJ, Yen MY, Wei YH. The effect of photo-oxidative stress and inflammatory cytokine on complement factor H expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2011;52(9):6832–41.View ArticlePubMedGoogle Scholar
- Rohrer B, Long Q, Coughlin B, Wilson RB, Huang Y, Qiao F, Tang PH, Kunchithapautham K, Gilkeson GS, Tomlinson S. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50(7):3056–64.View ArticlePubMedPubMed CentralGoogle Scholar
- Battle TE, Lynch RA, Frank DA. Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis. Cancer Res. 2006;66(7):3649–57.View ArticlePubMedGoogle Scholar
- Pappu R, Ramirez-Carrozzi V, Ota N, Ouyang W, Hu Y. The IL-17 family cytokines in immunity and disease. J Clin Immunol. 2010;30(2):185–95.View ArticlePubMedGoogle Scholar
- Ardeljan D, Wang Y, Park S, Shen D, Chu XK, Yu CR, Abu-Asab M, Tuo J, Eberhart CG, Olsen TW et al. Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. PLoS One. 2014;9(4):e95900.View ArticlePubMedPubMed CentralGoogle Scholar
- Sakurada Y, Nakamura Y, Yoneyama S, Mabuchi F, Gotoh T, Tateno Y, Sugiyama A, Kubota T, Iijima H. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Ophthalmic Res. 2015;53(1):2–7.View ArticlePubMedGoogle Scholar
- Tay SS, Plain KM, Bishop GA. Role of IL-4 and Th2 responses in allograft rejection and tolerance. Curr Opin Organ Transplant. 2009;14(1):16–22.View ArticlePubMedGoogle Scholar
- Lin T, Walker GB, Kurji K, Fang E, Law G, Prasad SS, Kojic L, Cao S, White V, Cui JZ et al. Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye. Cytokine. 2013;62(3):369–81.View ArticlePubMedPubMed CentralGoogle Scholar
- Lee KY, Vithana EN, Mathur R, Yong VH, Yeo IY, Thalamuthu A, Lee MW, Koh AH, Lim MC, How AC et al. Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2008;49(6):2613–9.View ArticlePubMedGoogle Scholar
- Lima LH, Schubert C, Ferrara DC, Merriam JE, Imamura Y, Freund KB, Spaide RF, Yannuzzi LA, Allikmets R. Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy. Ophthalmology. 2010;117(8):1567–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Liang XY, Lai TY, Liu DT, Fan AH, Chen LJ, Tam PO, Chiang SW, Ng TK, Lam DS, Pang CP. Differentiation of exudative age-related macular degeneration and polypoidal choroidal vasculopathy in the ARMS2/HTRA1 locus. Invest Ophthalmol Vis Sci. 2012;53(6):3175–82.View ArticlePubMedGoogle Scholar
- Zhang X, Wen F, Zuo C, Li M, Chen H, Wu K. Association of genetic variation on chromosome 9p21 with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(11):8063–7.View ArticlePubMedGoogle Scholar
- Zuo C, Wen F, Li M, Zhang X, Chen H, Wu K, Zeng R. COL1A2 polymorphic markers confer an increased risk of neovascular age-related macular degeneration in a Han Chinese population. Mol Vis. 2012;18:1787–93.PubMedPubMed CentralGoogle Scholar